Immunity to Covid-19 rapidly declines, research shows
Two new studies show that patients who have recovered from coronavirus rapidly lose antibodies, raising questions over how long immunity to the disease lasts and how reliable antibody testing is.
The studies also highlight the importance the development of a vaccine is to controlling the disease.
One study found that 10 per cent of patients hospitalised with Covid-19 in China had undetectable antibodies just weeks after recovering from the disease...
The other antibody study, published in the journal Nature Medicine, compared two groups of people who contracted the disease in Wanzhou, China in February. They looked at 37 people who had asymptomatic cases of the disease and 37 who had more severe forms.
They found that 40 per cent of people in the asymptomatic group had undetectable levels of antibodies two to three months after the infection, compared to 13 per cent in the group who had a more severe dose of the disease.
Prof Liam Smeeth, professor of clinical epidemiology at the London School of Hygiene and Tropical Medicine, commenting on the Nature Medicine study, said there were “marked reduction” in immunity among people who had symptoms of Covid-19.
“This strongly suggests that immunity may well diminish within months of infection for a substantial proportion of people. We need larger studies with longer follow-up in more populations, but these findings do suggest that we cannot rely on people having had proven infections nor on antibody testing as strong evidence of long term immunity.”
The studies also highlight the importance the development of a vaccine is to controlling the disease.
One study found that 10 per cent of patients hospitalised with Covid-19 in China had undetectable antibodies just weeks after recovering from the disease...
The other antibody study, published in the journal Nature Medicine, compared two groups of people who contracted the disease in Wanzhou, China in February. They looked at 37 people who had asymptomatic cases of the disease and 37 who had more severe forms.
They found that 40 per cent of people in the asymptomatic group had undetectable levels of antibodies two to three months after the infection, compared to 13 per cent in the group who had a more severe dose of the disease.
Prof Liam Smeeth, professor of clinical epidemiology at the London School of Hygiene and Tropical Medicine, commenting on the Nature Medicine study, said there were “marked reduction” in immunity among people who had symptoms of Covid-19.
“This strongly suggests that immunity may well diminish within months of infection for a substantial proportion of people. We need larger studies with longer follow-up in more populations, but these findings do suggest that we cannot rely on people having had proven infections nor on antibody testing as strong evidence of long term immunity.”